Silvia De Francia

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo et al. · Endocrine Related Cancer · 2008 · 165 citations · Full text

Mitotane Toxicity, Adrenal Gland, Oncology +12

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

Paola Sperone, Annamaria Ferrero, Fulvia Daffara et al. · Endocrine Related Cancer · 2010 · 162 citations · Full text

Advanced Acc Progressing, Second-/third-line Chemotherapy, Adrenocortical Carcinoma +13

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

Alfredo Berruti, Paola Sperone, Annamaria Ferrero et al. · European Journal of Endocrinology · 2011 · 134 citations

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

Massimo Terzolo, Aurélie Baudin, Arianna Ardito et al. · European Journal of Endocrinology · 2013 · 132 citations · Full text

New HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma

Silvia De Francia, Antonio D’Avolio, Francesca Martino et al. · Journal of Chromatography B · 2009 · 114 citations

Hematological Malignancy, Therapeutic Drug Monitoring, Health Sciences +13